How Decentralized AI is Unlocking Value in Cardiac Diagnostics

Five companies—VentriPoint Diagnostics, HeartBeam, Heartflow, Hyperfine, and GE Healthcare Technologies—are advancing AI-enabled cardiac diagnostic platforms to address the global heart disease crisis. Recent developments include VentriPoint's partnership with First Light Health for remote Indigenous communities, HeartBeam's collaboration with Mount Sinai on AI-ECG algorithms, Heartflow's new clinical registry data, Hyperfine's breakthrough stroke detection results, and GE Healthcare's role in the EU's COMPASS cardiotoxicity initiative.

03/27/2026, 9:30 AM • Benzinga

Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic

AI-driven clinical intelligence is transforming medical imaging, with point-of-care diagnostics projected to reach $70.92 billion by 2032. The CMS ACCESS Model launching in July 2026 will reward outcome-based care, driving adoption of software-defined imaging platforms. Key players including VentriPoint Diagnostics, Butterfly Network, Hyperfine, Hologic, and GE HealthCare are advancing portable, AI-powered diagnostic solutions that deliver hospital-grade precision at the bedside, reducing facility overhead while improving patient outcomes.

01/16/2026, 11:56 AM • Benzinga

Hyperfine Q2 Revenue Jumps 26 Percent

Hyperfine reported Q2 2025 results with $2.7 million revenue, 26% sequential increase, and eight system sales. The company achieved FDA clearances, expanded gross margins to 49.3%, and reduced cash burn by 19%, projecting 10-20% revenue growth for the year.

08/14/2025, 7:29 AM • The Motley Fool